US Patent Issued to Senju Pharmaceutical, Mochia Pharmaceutical on Jan. 20 for "Suspension containing heterocyclidene acetamide derivative" (Japanese Inventor)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,740, issued on Jan. 20, was assigned to Senju Pharmaceutical Co. Ltd. (Osaka, Japan) and Mochia Pharmaceutical Co. Ltd. (Tokyo).

"Suspension containing heterocyclidene acetamide derivative" was invented by Yuki Yamashita (Osaka, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides suspendable ophthalmic solutions with excellent redispersibility. The present disclosure provides an aqueous suspension agent comprising (E)-2-(7-trifluoromethylchroman-4-ylidene)-N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide or a pharmaceutically acceptable salt or solvate thereof, a cellulosic polymer, and a nonionic surfactant....